Please enter your credentials to continue.
Asia
Africa
Australia
China
Europe
Canada
Middle East
United Kingdom
United States
>>
The FDA suspends two Regenxbio gene therapy trials over safety concerns after a study participant developed a brain tumor. The U.S. Food and Drug Adm...
Johnson & Johnson projects it can achieve $100 billion in annual sales, driven by strong growth in its oncology and immunology pharmaceutical port...
Vaccine manufacturers are bracing for impact as Health Secretary Kennedy's anti-establishment rhetoric transforms into hard-line policy and aggressive...
Key themes from JPMorgan's 2026 healthcare conference include patient cash pay for obesity drugs, renewed biotech IPO optimism, and pharma's strategic...
Radiopharmaceutical firm Aktis Oncology has raised $318 million in 2026's first biotech IPO, backed by partner Eli Lilly, marking a major resurgence f...